Farmacia
Facultad
Hospital Infanta Sofia
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Infanta Sofia (20)
2024
2023
-
AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907
-
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors
European Journal of Hospital Pharmacy
-
Medicamentos inmunosupresores y biológicos en el embarazo, la lactancia y la fertilidad en enfermedades inmunomediadas
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 39-49
-
Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625
-
The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors
Vaccines, Vol. 11, Núm. 10
2022
-
Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain
Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 327-334
-
Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort
Journal of Acquired Immune Deficiency Syndromes, Vol. 90, Núm. 1, pp. 62-68
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 28, Núm. 2, pp. e348-e352
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352
-
Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain
AIDS Research and Human Retroviruses, Vol. 38, Núm. 6, pp. 433-440
2021
-
HIV postexposure prophylaxis during the COVID-19 pandemic: Experience from Madrid
Sexually Transmitted Infections
2020
-
Lyophilized Autologous Serum Eyedrops: Experimental and Comparative Study
American Journal of Ophthalmology, Vol. 213, pp. 260-266
2019
-
Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient
Clinical Drug Investigation, Vol. 39, Núm. 11, pp. 1125-1131
-
Safe and successful protocol for desensitization to abiraterone
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 386-387
2018
-
Intravenous iron, functional recovery and delirium in patients with hip fracture. FEDEREF study. Single-centre randomised, placebo-controlled, and double-blind clinical trial. 2014-001923-53: EudraCT number
Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 1, pp. 38-44
2016
-
Stability of Growth Factors in Autologous Serum Eyedrops after Long-Term Storage
Current Eye Research, Vol. 41, Núm. 3, pp. 292-298
2014
-
Autologous serum eye drops diluted with sodium hyaluronate: Clinical and experimental comparative study
Acta Ophthalmologica, Vol. 92, Núm. 1